SLC2A1 and HIV-1 infection: CD4+ T cells expressing Glut1 show higher levels of activation marker as well as HIV-1 co-receptor CCR5 compared with CD4+Glut1- cells and blockade of glycolysis pathway by PI3K inhibitor could suppress HIV-1 infection in vitro (52).